Panion develops a gene therapy treatment for dogs with epilepsy. The clinical trial in dogs with real epilepsy will take place in the large investigator clinic, Long Island Veterinary Specialists (LIVS) in New York, USA. The study procedures are advancing well in...
Panion Animal Health AB develops an innovative gene therapy treatment for epilepsy in dogs. The development product CG01-canine has just entered the clinical phase with an ongoing dog study in USA. This study will explore the efficacy of the product in drug-refractory...
Panion Animal Health AB develops a gene therapy product for treatment of epilepsy in dogs, for which the clinical phase has started. Panion’s highly competent advisory board has now been expanded with the fourth member, Dr. Dominic J. Marino, DVM, DACVS, DACCT, CCRP,...
